83: Drug Resistant Thyroid Cancer, with Dr. Carmelo Nucera from Harvard Medical School

Carmelo Nucera, M.D., Ph.D., is currently an Assistant Professor at Harvard Medical School, Boston, in the Division of Cancer Biology and Angiogenesis (Department of Pathology), Beth Israel Deaconess Medical Center. Dr. Nucera received his M.D. and Ph.D. in Experimental Endocrinology and Metabolism from Italy. In this episode, Dr. Nucera discusses a combination drug therapy using vemurafenib and palbociclib represents a novel therapeutic strategy to treat papillary thyroid carcinoma (PTC). 

Continue Reading83: Drug Resistant Thyroid Cancer, with Dr. Carmelo Nucera from Harvard Medical School

82: Pregnancy and Thyroid⎥Hypothyroidism and Hyperthyroidism, with Dr. Angela Leung from UCLA

In this episode, the following topics are explained: * Optimizing thyroid health prior to conception * Thyroid issues that affect pregnancy * Hypothyroid as result of surgery or Hashimotos * Hyperthyroidism and pregnancy * Adjusting current thyroid treatment, meaning optimizing thyroid levels by adjusting dosage of thyroid medication * TSH levels in light of pregnancy * Planned pregnancy usually means a dose increase

Continue Reading82: Pregnancy and Thyroid⎥Hypothyroidism and Hyperthyroidism, with Dr. Angela Leung from UCLA

81: Recovering From Thyroid Cancer Surgery, Faster, Better, and Stronger with Evan Simon, Head Strength & Conditioning Coach at Oregon State University

In this episode, we hear from Evan Simon, Head Strength and Conditioning Coach at Oregon State University. Evan was diagnosed with advanced Stage IV thyroid cancer, which resulted a 13 hour surgery. At the end of his surgery, Evan was told he would not be able to lift his hands overhead for 3 months, instead he broke the odds, taking him only 3 weeks.

Continue Reading81: Recovering From Thyroid Cancer Surgery, Faster, Better, and Stronger with Evan Simon, Head Strength & Conditioning Coach at Oregon State University

80: Everything You Need to Know About Thyroid Nodules with Dr. Regina Castro from Mayo Clinic

60% of people in the U.S. have thyroid nodules, and almost all are benign — the others maybe reason for concern. M. Regina Castro, MDis a consultant in the Division…

Continue Reading80: Everything You Need to Know About Thyroid Nodules with Dr. Regina Castro from Mayo Clinic

79: No Biopsy is 100% Accurate⎥Molecular Testing Gets Close, with Dr. Bridget Brady from Austin Thyroid Surgeons

Dr. Bridget Brady is Austin's first fellowship-trained endocrine surgeon. In this episode the following topics are discussed: Austin Thyroid Surgeons sees 30 patients per week with thyroid nodules Up to 80% of US population could have a thyroid nodule(s) less than 5% of Dr Brady's thyroid nodule patients test positive for cancer How relevant is what I don’t know won’t hurt me in thyroid cancer and biopsies of nodules? BETHESDA system or the middle category, also known as indeterminate For thyroid nodules that are indeterminate, historically a surgery would be performed  With molecular testing, surgery can be decreased by up to 50% Afirma molecular testing uses messenger RNA If Afirma comes back suspicious it does NOT necessarily mean it is cancer

Continue Reading79: No Biopsy is 100% Accurate⎥Molecular Testing Gets Close, with Dr. Bridget Brady from Austin Thyroid Surgeons

78: The Gut⎥Antibiotics Danger, Fixing Inflammation, and Thyroid Health, with Dr. Lisa Sardinia

Dr. Lisa Sardinia is an associate professor in the Pacific University Biology Department. In this episode we discuss: Majority of antibiotics given to children under three are for upper respiratory issues, fact is antibiotics do not work for such issues 85% of antibiotics used are given to food sources, and released into the environment including soil and water Danger of consuming emulsifiers Cow’s milk US has low gut diversity — more diversity means more resilience Autism and gut connection Resetting your gut microbiota by changing diet

Continue Reading78: The Gut⎥Antibiotics Danger, Fixing Inflammation, and Thyroid Health, with Dr. Lisa Sardinia

77: Levothyroxine and Hair Loss⎥Thyroid Health, with Dr. Susanne Breen

In this episode, the following topics are discussed: * Fatigue, hair loss, weight gain, anxiety, and depression. * Sub-clinical hypothyroidism * Standard range for TSH has changed over the years, .5 - 1.5 TSH is optimal * Armour Thyroid vs Levothyroxine * If antibodies are involved than it is most likely related to the gut * Getting off thyroid medication * Testing: TSH, free T3 T4, TPO antibodies, reverse T3 * Getting motivated and inspired by fixing thyroid * Selenium * Iodine * Thyroid supplements * Treating fertility

Continue Reading77: Levothyroxine and Hair Loss⎥Thyroid Health, with Dr. Susanne Breen

76: Hypothyroidism — Diagnosis, Treatment, and Medication with Dr. Leonard Wartofsky from MedStar

Dr. Wartofsky is Professor of Medicine, Georgetown University School of Medicine and Chairman Emeritus, Department of Medicine, MedStar Washington Hospital Center.  He trained in internal medicine at Barnes Hospital, Washington University and in endocrinology with Dr. Sidney Ingbar, Harvard University Service, Thorndike Memorial Laboratory, Boston.   In this episode, Dr. Wartofsky discusses the following: * Hypothyroidism causes * When is replacement thyroid replacement hormone necessary? * The history of replacement thyroid hormone going back to 1891 * The early treatment included a chopped up sheep thyroid and served as a 'tartar', often resulting in vomiting * Myxedema coma

Continue Reading76: Hypothyroidism — Diagnosis, Treatment, and Medication with Dr. Leonard Wartofsky from MedStar

75: Thyroid Cancer Does Not Respond to RAI⎢Treatment Options

In this episode, topics include: * Drug therapy for patients that fail standard therapy; including surgery and RAI * Not all patients have same behavior for their cancer * Some cancers are aggressive * Not many thyroid cancer patients are affected by this; maybe a few thousand in the U.S., but not tens of thousands * What is the treatment protocol for therapy? * Lenvatinib or Sorafenib is the treatment for refectory thyroid cancer * Lenvatinib tends to be more effective * Sorafenib is tolerated by the patient better * Other options to consider include, molecular profiling or some thyroid cancers carry mutation that is targetable, or BRAF * BRAF inhibitors used with thyroid cancer patients * Molecular profiling * DNA sequencing

Continue Reading75: Thyroid Cancer Does Not Respond to RAI⎢Treatment Options

74: Thyroid and Pregnancy⎥Why It Matters, with Dr. Elizabeth Pearce from Boston University

In this episode, topics include: * Hypothyroidism and hyperthyroidism during pregnancy * Pregnant and without a thyroid * Avoiding T3 during pregnancy, including concerns with desiccated thyroid * If being treated for hypothyroidism already, the importance of upping dose while pregnant * Pregnant with auto-immunity * Pregnant with Graves' disease * The dangers of pregnancy and overt hypothyroidism or hyperthyroidism

Continue Reading74: Thyroid and Pregnancy⎥Why It Matters, with Dr. Elizabeth Pearce from Boston University